Trial NCT00039455

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2013-00035
Secondary IDs: 01-177 CDR0000069385 P50CA089393

Last trial update was posted on 2013-02-01

MeSH Interventions

Alvocidib Trastuzumab

MeSH Conditions

Breast Neoplasms Breast Neoplasms, Male

Other Conditions

HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID